FDA Genomics Guidance Paves Way For PKG Firms; Genaissance May Benefit

Genaissance Pharmaceuticals is developing a pharmacogenomics-based assay for predicting an individual occurrence of agranulocytosis associated with the antipsychotic clozapine (Novartis' Clozaril and generics)